Knoa Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for KNOA PHARMA
KNOA PHARMA has seven approved drugs.
There are forty-two US patents protecting KNOA PHARMA drugs.
Summary for Knoa Pharma
| US Patents: | 42 |
| Tradenames: | 7 |
| Ingredients: | 6 |
| NDAs: | 7 |
Drugs and US Patents for Knoa Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Knoa Pharma | HYSINGLA ER | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627-005 | Nov 20, 2014 | AB | RX | Yes | No | 9,095,614 | ⤷ Start Trial | ⤷ Start Trial | |||
| Knoa Pharma | HYSINGLA ER | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627-006 | Nov 20, 2014 | AB | RX | Yes | No | 9,486,413 | ⤷ Start Trial | Y | ⤷ Start Trial | ||
| Knoa Pharma | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-005 | Apr 5, 2010 | RX | Yes | Yes | 9,492,393 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Knoa Pharma | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-001 | Apr 5, 2010 | RX | Yes | No | 11,304,908 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Knoa Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Knoa Pharma | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-006 | Apr 5, 2010 | 9,675,610 | ⤷ Start Trial |
| Knoa Pharma | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-005 | Apr 5, 2010 | 10,696,684 | ⤷ Start Trial |
| Knoa Pharma | HYSINGLA ER | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627-006 | Nov 20, 2014 | 8,551,520 | ⤷ Start Trial |
| Knoa Pharma | HYSINGLA ER | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627-005 | Nov 20, 2014 | 8,647,667 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for KNOA PHARMA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Transdermal System | 15 mcg/hr | ➤ Subscribe | 2013-12-16 |
| ➤ Subscribe | Extended-release Tablets | 30 mg, 40 mg, 80 mg, and 100 mg | ➤ Subscribe | 2015-05-08 |
| ➤ Subscribe | Extended-release Tablets | 30 mg and 60 mg | ➤ Subscribe | 2007-01-03 |
| ➤ Subscribe | Transdermal System | 5 mcg/hr, 10 mcg/hr, and 20 mcg/hr | ➤ Subscribe | 2013-06-06 |
| ➤ Subscribe | Extended-release Tablets | 20 mg, 60 mg, and 120 mg | ➤ Subscribe | 2015-04-15 |
| ➤ Subscribe | Extended-release Tablets | 15 mg | ➤ Subscribe | 2007-02-15 |
International Patents for Knoa Pharma Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Denmark | 2082742 | ⤷ Start Trial |
| Tunisia | 2009000059 | ⤷ Start Trial |
| Philippines | 12015501411 | ⤷ Start Trial |
| Chile | 2007002485 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Knoa Pharma Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1685839 | 92292 | Luxembourg | ⤷ Start Trial | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
